American Diabetes Association Announces Retirement of Chief Scientific & Medical Officer, Dr. Richard Kahn

December 16, 2008

The American Diabetes Association announced today that Richard A. Kahn, PhD, its Chief Scientific and Medical Officer, will be retiring in June 2009.

Kahn has been with the American Diabetes Association since 1985 and has provided senior staff oversight for the Association’s research grant program, two certification programs, clinical guidelines, professional education programs, and general information resources.

Kahn will remain with the Association through its annual Scientific Sessions, the world’s largest diabetes-related clinical and scientific meeting, in June. He also will consult on a number of projects for the American Diabetes Association through the end of 2009.

“No one who has worked directly with Dr. Kahn can doubt his passion for the science and medicine of diabetes, or his dedication to working toward a cure,” said Larry Hausner, ADA’s CEO.

Under Kahn’s leadership, the Association first began publishing clinical practice guidelines. He also led the initiation of the Association’s two Recognition Programs, Consensus Development Conferences and Research Symposia. His work led the effort which resulted in the first set of diabetes-specific performance measures that are now used by Medicare, Medicaid and virtually all health plans to track the delivery of quality diabetes care. In the late ‘90s, Kahn led the initiation of a major revision of the diagnostic criteria that are now used world-wide to diagnose diabetes, and also ushered in the concept of impaired fasting glucose.

Internationally, he began the Association’s efforts to bring continuing medical education programs to many developing countries, programs that are now routinely held throughout India and the Middle East. More recently, he was instrumental in the development and implementation of the first comprehensive health risk assessment tool in medicine, which is now on the Association’s website (the Diabetes PHD).

“We owe Dr. Kahn a great deal of gratitude,” Hausner said. “In his long and distinguished tenure, he has been instrumental in establishing the American Diabetes Association as the authoritative voice on diabetes and his tenure has been marked by achievements that have improved the lives of people with diabetes and all those affected by diabetes.”

About the American Diabetes Association

Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)